carbapenems has been researched along with Kidney Diseases in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Hu, Q; Liu, YP; Long, WM; Qu, J; Qu, Q; Wang, Q; Wu, XL; Xiao, YW; Xu, TT; Zhuang, HH | 1 |
| Katip, W; Oberdorfer, P; Uitrakul, S | 1 |
| Kaye, KS; Ortwine, JK; Pogue, JM; Sutton, JD | 1 |
| Arah, OA; Chow, AL; Lye, DC | 1 |
| Keam, SJ | 1 |
| Ha, JR; Kim, BO; Kim, HG; Kim, JG; Kim, JM; Lee, DG; Lee, JM; Lee, SH; Oh, SW | 1 |
| Aslamkhan, AG; Bailey, W; Clouse, H; Figueroa, DJ; Gerhold, DL; Holder, D; Jin, H; Muniappa, N; Ozer, JS; Seng, J; Shi, S; Shughrue, P; Sistare, FD; Su, M; Thudium, D; Troth, SP; Villarreal, S; Yu, Y | 1 |
| Bailey, WJ; Chibout, SD; Clouse, HK; Cordier, A; Dieterle, F; Erdos, Z; Forest, T; Gerhold, DL; Glaab, WE; Grenet, O; Holder, D; Jin, H; Legay, F; Mahl, A; Maurer, G; Muniappa, N; Ozer, JS; Perentes, E; Reynolds, S; Roth, DR; Sina, JF; Sistare, FD; Skopek, TR; Staedtler, F; Thudium, DT; Topper, MJ; Troth, S; Verdes, P; Vlasakova, K; Vonderscher, J; Wahl, D; Yu, Y | 1 |
| Abe, T; Goto, K; Hagiwara, S; Hidaka, S; Nishida, T; Noguchi, T; Ohchi, Y; Shitomi, R; Yamamoto, S; Yasuda, N | 1 |
| Sakamoto, M; Shiba, K | 1 |
| Hirouchi, Y; Hori, R; Inui, K; Kamiya, A; Kawahara, Y; Naganuma, H; Okada, R | 1 |
| Matsumura, H; Nouda, H; Sunagawa, M; Tanio, T | 1 |
| Jacolot, A; Leotard, S; Louchahi, K; Mimoz, O; Nordmann, P; Padoin, C; Petitjean, O | 1 |
| Goonetilleke, UR; Jones, DV; Murgatroyd, LB; Topham, JC; Wright, J | 1 |
| Brughera, M; Ferrari, ML; Mazué, G; Nava, A; Scampini, G | 1 |
3 review(s) available for carbapenems and Kidney Diseases
| Article | Year |
|---|---|
Strategies for the safe use of colistin.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance; Gram-Negative Bacteria; Humans; Kidney Diseases | 2015 |
Doripenem: a review of its use in the treatment of bacterial infections.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Humans; Kidney Diseases; Tissue Distribution | 2008 |
[Nephrotoxicity of anti-infective agents].
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Humans; Kidney Diseases; Penicillins; Peptides | 2003 |
12 other study(ies) available for carbapenems and Kidney Diseases
| Article | Year |
|---|---|
Efficacy and mortality of ceftazidime/avibactam-based regimens in carbapenem-resistant Gram-negative bacteria infections: A retrospective multicenter observational study.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Ceftazidime; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Kidney Diseases; Microbial Sensitivity Tests; Retrospective Studies | 2023 |
The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Kidney; Kidney Diseases; Male; Meropenem; Middle Aged; Retrospective Studies; Thailand | 2020 |
Patient and physician predictors of patient receipt of therapies recommended by a computerized decision support system when initially prescribed broad-spectrum antibiotics: a cohort study.
Topics: Academic Medical Centers; Aged; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Decision Support Systems, Clinical; Drug Therapy, Computer-Assisted; Drug Utilization; Female; Guideline Adherence; Humans; Inappropriate Prescribing; Intensive Care Units; Kidney Diseases; Male; Middle Aged; Patient Admission; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Singapore | 2016 |
Comparison of in vivo nephrotoxicity in the rabbit by a pyrrolidinyl-thio Carbapenem CW-270031.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Cilastatin; Imipenem; Kidney; Kidney Diseases; Male; Meropenem; Pyrrolidines; Rabbits; Thienamycins | 2008 |
Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury.
Topics: Albuminuria; Animals; Biomarkers, Pharmacological; Carbapenems; Cisplatin; Gentamicins; Histocytochemistry; Iridoid Glycosides; Iridoids; Kidney Diseases; Kidney Tubules; Logistic Models; Neuropeptides; Rats; ROC Curve; Trefoil Factor-3 | 2010 |
A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function.
Topics: Animals; Biomarkers, Pharmacological; Blood Urea Nitrogen; Carbapenems; Creatinine; Cystatin C; Drug-Related Side Effects and Adverse Reactions; Female; Gentamicins; Kidney; Kidney Diseases; Kidney Function Tests; Male; Rats; Rats, Sprague-Dawley; Rats, Wistar; ROC Curve | 2010 |
Effect of hemopurification rate on doripenem pharmacokinetics in critically ill patients receiving high-flow continuous hemodiafiltration.
Topics: Aged; Aged, 80 and over; Carbapenems; Chromatography, High Pressure Liquid; Critical Illness; Doripenem; Female; Hemodiafiltration; Humans; Kidney Diseases; Male; Middle Aged; Severity of Illness Index; Time Factors | 2011 |
Preventive effect of betamipron on nephrotoxicity and uptake of carbapenems in rabbit renal cortex.
Topics: Alanine; Animals; Carbapenems; Glycosuria, Renal; Imipenem; In Vitro Techniques; Kidney Cortex; Kidney Diseases; Male; Necrosis; Proteinuria; Rabbits; Thienamycins | 1994 |
Structural features of carbapenem compounds for nephrotoxicity: effect of C-2 side chain.
Topics: Animals; Carbapenems; Kidney Diseases; Kidney Tubules, Proximal; Male; Rabbits; Structure-Activity Relationship | 1996 |
Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Creatinine; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Half-Life; Imipenem; Kidney Diseases; Male; Meropenem; Penicillinase; Pneumonia, Bacterial; Protein Binding; Rats; Rats, Wistar; Thienamycins; Uranyl Nitrate | 2000 |
Safety evaluation of meropenem in animals: studies on the kidney.
Topics: Animals; Anti-Bacterial Agents; Blood Chemical Analysis; Carbapenems; Cefotaxime; Ceftazidime; Cephaloridine; Female; Kidney Diseases; Macaca fascicularis; Male; Meropenem; Rabbits; Rats; Rats, Inbred Strains; Species Specificity; Thienamycins | 1989 |
Toxicological profile of FCE 22101 and its orally available ester FCE 22891.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Female; Kidney Diseases; Lactams; Lethal Dose 50; Male; Mice; Mice, Inbred Strains; Rats; Time Factors | 1989 |